Ocean Biomedical, Inc. (OCEA)

1,4200 +0,0300 (+2,16%) Al cierre: 04:00PM EDT

Ocean Biomedical, Inc.

Room 325, 55 Claverick Street
Providence, RI 02903
United States
401 444 7375
https://www.oceanbiomedical.com

Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Ms. Elizabeth Ng M.B.A.	CEO & Director	N/A	N/A	1957
Dr. Inderjote Kathuria M.B.A., M.D.	Chief Strategy Officer	N/A	N/A	1967
Dr. Chirinjeev Baboo Kathuria M.B.A., M.D.	Founder & Executive Chairman of the Board	N/A	N/A	1965
Dr. Jack A. Elias M.D.	Founder, Chairman of Scientific Advisory Board & Independent Director	N/A	N/A	1951
Dr. Jonathan Kurtis M.D., Ph.D.	Founder, Chairman of Scientific Advisory Board & Director	N/A	N/A	1969
Ms. Jolie G. Kahn C.P.A., Esq.	Chief Financial Officer	N/A	N/A	1965
Mr. Robert John Sweeney	Chief Accounting Officer & Assistant Secretary	N/A	N/A	1965

Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.

Gobierno corporativo

El ISS Governance QualityScore de Ocean Biomedical, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.